-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.50-11.08% Downside
Lifecore Biomedical, Inc. Frequently Asked Questions
-
What analysts cover Lifecore Biomedical, Inc.?
Lifecore Biomedical, Inc. has been rated by research analysts at Stephens, Craig-Hallum in the past 90 days.